胃内肉毒素注射和肉毒症:临床医生的警报
Mojtaba Mojtahedzadeh1, Farhad Najmeddin1, Elham Pourheidar2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Case reports in critical care
|May 8, 2024
概括
胃内毒素A注射治疗肥胖可能会导致肉毒症,这是一个严重的不良影响. 医生必须意识到这些风险,并在考虑这种新型治疗时确保患者的安全.
科学领域:
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- 肉毒杆菌产生肉毒毒素A (BTXA),一种强大的神经毒素,具有治疗和化品用途.
- 胃内BTXA注射是一种新兴的肥胖治疗方法,由于肝不活化或胃壁代谢,被认为是安全的.
研究的目的:
- 报告肥胖症的胃内BTXA注射后发生的肉毒症病例.
- 突出这一新型治疗的潜在危及生命的不良影响.
主要方法:
- 一份病例报告详细介绍了一名36岁的女性,在胃内注射BTXA后患上了肉毒症.
- 描述了临床表现,症状和重症监护室的入院情况.
主要成果:
- 患者在注射后两天出现了双眼视,肺,肌肉虚弱和呼吸困难.
- 延迟症状包括消化不良,声,便秘,低血症和低质症.
结论:
- 针对肥胖的胃内BTXA注射带有潜在致命的肉毒的风险.
- 医生需要对这种方法及其严重不良影响有全面的了解.
更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
674
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
674
Skeletal Muscle Relaxants: Therapeutic Uses
481
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
481
Prevention of Further Absorption of Poison
817
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
817
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
117
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
117
Depolarizing Blockers: Pharmocokinetics
322
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
322
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K


